The GIAR International Symposium

第14回群馬大学未来先端研究機構国際シンポジウム

2024.02.14 (wed)
9：00〜17：30 (JST) OPEN 8:45-

シンポジウム終了後、情報交換会を開催予定
Please enjoy face-to-face discussion after the symposium.

群馬大学未来先端研究機構 ウイルスベクター開発研究センター
平井宏和センター長
GIAR Viral Vector Core Director
Hirokazu Hirai

Prof. Luís Pereira de Almeida (University of Coimbra, Portugal)

Dr. Irene Ferreira (Revvity Inc., Germany)

Dr. Masafumi Onodera (NCCHD, Japan)

Prof. Shin-ichi Muramatsu (Jichi Medical University, Japan)

Dr. Yoshinori Tanaka (Takara Bio Inc., Japan)

Dr. Shunsuke Saito (Synplogen Co., Ltd., Japan)

* すべて英語でのご講演/ All Speech in English

ミレニアムホール(群馬大学昭和キャンパス)(Googleマップが開きます)
〒371-8511　群馬県前橋市昭和町3丁目39-22
群馬大学昭和キャンパス
(ミレニアムホールは保健学科・保健学研究科新棟内にあります)

事前登録が必要です。以下からお申し込みください。【申し込み締切】2024.02.07 (水)

Pre-registration is required and please register from below.
[Application Deadlines] 2024.02.07 [Wed.]

[事前登録フォーム／Pre-registration Form]

https://forms.gle/7E239H3sNT6yaXCf9

※ポスター発表を募集します。事前登録フォームよりご応募ください。

　Call for posters is now open. Please apply via the pre-registration form.

Time	Program	Speakers
9:00 –	Welcome Address
9:10 –	GIAR Session	Dr. Hirokazu Hirai Director, GIAR Viral Victor Core / Professor, Gunma University Graduate School of Medicine Dr. Izuho Hatada Professor, GIAR Viral Victor Core / Gunma University Institute for Molecular and Cellular Regulation Dr. Keisuke Nimura Professor, GIAR
10:45 –	Industry Session Ⅰ	Dr. Yoshinori Tanaka Senior Manager, Technology Development Center, Takara Bio Inc. (Japan)
11:20 –	Education Session Ⅰ	Dr. Masafumi Onodera Director, Gene and Cell Therapy Promotion Center, National Center for Child Health and Development (Japan)

[Lunch Break]

13:30 –	Keynote Session	Dr. Luís Pereira de Almeida Professor, Center for Neuroscience and Cell Biology, University of Coimbra (Portugal)
14:40 –	Industry Session Ⅱ	Dr. Shunsuke Saito Director, Medical Business Unit, Synplogen Co., Ltd. (Japan) Dr. Irene Ferreira Head of Cell and Gene Therapy Platform Innovation & Management, Revvity Inc. (Germany)
16:00 –	Poster Viewing
16:30 –	Education Session Ⅱ	Dr. Shin-ichi Muramatsu Professor, Division of Neurological Gene Therapy, Center for Open Innovation, Jichi Medical University (Japan)
17:10 –	Closing Remarks